Figure 3 visualizes best radiologic response annotated by HRD status. Notably, patients with HRDpos tumors were more likely to experience deep radiologic responses regardless of treatment arm. Additionally, no pathogenic variants in BRCA1/2 or in other HRR genes were present in samples from patients who had radiologic tumor growth as best response. Here, BRCA1 is linked to neoplasm.